AFT Pharmaceuticals Ltd 2020 Annual Report with Sustainability Disclosures
Company: AFT Pharmaceuticals Ltd
Sector: Manufacturing
Country: New Zealand
Year: 2020
Type: Annual Report with Sustainability Disclosures
Pages: 43
The report records a 24% increase in total revenue to $105.6 million and continued growth across Australia, New Zealand, Southeast Asia and international markets. It highlights the global commercialisation of Maxigesic, including sales in 28 countries and licensing across more than 125 territories. Sustainability disclosures link company activities to eight Sustainable Development Goals, including health, gender equality, decent work and partnerships. The report also reports 86 employees across 29 cultural backgrounds, with women representing 58% of the workforce.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.